It had been expected the drug would be approved this year, but now it is likely it won't be approved for years.
Home / World Business
Sat, Jul 13, 2002 - Page 12 News List
SEC investigating Bristol-Myers Squibb
ACCOUNTING QUESTIONS The probe, which has been ongoing since April, is looking into the company's inventory glut that caused its earnings to be slashed
AP , NEW YORK
This story has been viewed 2650 times.
RSS